| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 2.775 | 13.554 | 48.414 | 127.164 |
| Total Income - EUR | - | - | - | - | - | - | 2.775 | 13.554 | 48.414 | 127.658 |
| Total Expenses - EUR | - | - | - | - | - | - | 1.191 | 4.367 | 35.106 | 126.687 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 1.583 | 9.187 | 13.308 | 971 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 1.500 | 8.780 | 11.424 | 759 |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | 2 |
Check the financial reports for the company - Badident Rx S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 3.292 | 2.476 | 4.980 | 80.939 |
| Current Assets | - | - | - | - | - | - | 1.603 | 9.919 | 24.132 | 52.120 |
| Inventories | - | - | - | - | - | - | 1.601 | 4.507 | 507 | 775 |
| Receivables | - | - | - | - | - | - | 0 | 573 | 0 | 1.753 |
| Cash | - | - | - | - | - | - | 2 | 4.840 | 23.625 | 49.592 |
| Shareholders Funds | - | - | - | - | - | - | 1.541 | 8.821 | 20.219 | 20.865 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 3.354 | 3.575 | 8.894 | 72.484 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 39.711 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Badident Rx S.r.l.